# EDGAR Filing Document

**Accession Number:** 0001175680
**File Stem:** 0001558370-25-011644
**Filing Date:** 2025-8
**Character Count:** 2356
**Document Hash:** 232250919d943170bed5f713024830ab
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001558370-25-011644.hdr.sgml**: 20250919

**ACCESSION NUMBER**: 0001558370-25-011644

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250818

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CytoDyn Inc.
- **CENTRAL INDEX KEY:** 0001175680
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 753056237
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0531

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 1111 MAIN STREET, SUITE 660
- **CITY:** VANCOUVER
- **STATE:** WA
- **ZIP:** 98660
- **BUSINESS PHONE:** 360-980-8524

**MAIL ADDRESS:**
- **STREET 1:** 1111 MAIN STREET, SUITE 660
- **CITY:** VANCOUVER
- **STATE:** WA
- **ZIP:** 98660

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CYTODYN INC
- **DATE OF NAME CHANGE:** 20031114

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** REXRAY CORP
- **DATE OF NAME CHANGE:** 20020617

![Graphic](cydy-20250818xcorresp001.jpg)

August 18, 2025

***VIA EDGAR***

Office of Life Sciences

Division of Corporation Finance<br>United States Securities and Exchange Commission<br>100 F Street, NE<br>Washington, DC 20549

***Attention: Alan Campbell***

**Re:** **CytoDyn Inc.**<br> **Registration Statement on Form S-3**<br> **File No. 333-288970**<br> **Request for Acceleration**

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, CytoDyn Inc. (the "Company") hereby respectfully requests acceleration of the effectiveness of the Company's Registration Statement on Form S-3 filed on July 25, 2025 (Registration No. 333-288970) (the "Registration Statement") so that the Registration Statement shall become effective at *8 am Eastern Time on August 21, 2025,* or as soon as possible thereafter.

We would appreciate notification by telephone of the effective date of the Registration Statement and confirmation of such effectiveness in writing.

If you have any questions about the foregoing request, please contact our counsel, Mary Ann Frantz of Miller Nash LLP at (503) 205-2552, or the undersigned at (360) 980-8524. Thank you.

---

| |
|:---|
| Very truly yours, |
| /s/ Robert Hoffman |
| Robert E. Hoffman |
| Chief Financial Officer |

---

------